healthcare
Peepul Capital backs India's Cura Healthcare
India-focused Peepul Capital has invested $6 million in Cura Healthcare, a high-end radiology equipment maker.
China menstruation-tracking app gets $30m Series C round
Ceyuan Ventures has led a $30 million Series C round of investment in Dayima.com, a Chinese menstruation cycle-tracking mobile app.
Australia's Ironbridge set for partial exit from Monash IVF
Australian GP Ironbridge Capital is on course to exit the majority of its stake in Monash IVF through an IPO.
SIGVC invests in China Resources’ online drug platform
Shanghai International Group Venture Capital (SIGVC) has provided a RMB300 million ($48 million) Series A round funding for J1.com, an online drug store launched by China Resources Holdings.
China to ease curbs on foreign investment in hospitals
China is to relax limits on foreign investment in joint-venture (JV) hospitals as part of efforts to deepen its healthcare reform.
AIP Japan to launch $300m healthcare focused fund
Asia Investment Partners (AIP) Japan is launching its sixth healthcare-focused fund, which will specifically target the elderly care home segment.
Accel-backed India medical advisory service bought by Ebix
Healthcare Magic, an India-based medical advisory service that won early backing from Accel Partners, has been acquired by NASDAQ-listed on-demand software and e-commerce services provider Ebix.
Hony completes $569m sell down of CSPC Pharma
Hony Capital has made a partial exit from Chinese generic drugs maker CSPC Pharmaceutical Group, generating HK$4.41 billion ($569 million).
Yunfeng raises more than $1b for China fund
Yunfeng Capital, a Chinese PE firm set up by Jack Ma and David Yu, founders of Alibaba Group and Target Media, respectively, has reached a final close of around $1.1 billion on its second fund.
IMC PE unit invests in Singapore's Q&M Dental
Heritas Helios Investments (HHI), a healthcare PE fund seeded by Singaporean conglomerate IMC, has acquired a 10% stake in Q&M Dental Group from existing shareholders for S$30 million ($24 million).
Japan's INCJ joins $8.2m deal for TB vaccine developer
The Innovation Network Corporation of Japan has made a joint investment with Osaka-based Dainippon Sumitomo Pharma and Japan BCG Laboratory in Create Vaccine Company, which is developing a new tuberculosis (TB) vaccine.
Standard Chartered commits $50m to Indonesia hospital business
Standard Chartered Private Equity (SCPE) has agreed to invest up to $50 million to support an Indonesian healthcare business being developed by domestic media giant Emtek Group.
IFC commits $147m to India's Jubilant Pharma
International Finance Corporation (IFC) has completed one of its largest investments in India’s healthcare sector, committing $147.5 million to Jubilant Pharma.
Taiwan's CDIB, Govtor Capital launch $320m PE fund
Taiwan’s CDIB Private Equity has teamed up with China’s state-owned Govtor Capital to create a RMB2 billion ($320 million) private equity fund.
Japan's Next Capital exits massage chair maker to Asahi
Next Capital has agreed to exit its stake in Fuji Medical Instruments (Fujiiryoki), a Japanese manufacturer of massage chairs and other health-related products, to Asahi Holdings for JPY7.8 billion ($76.7 million).
Taiwan's National Development Fund targets tech investments
Taiwan’s National Development Fund has committed NT$1.15 billion ($38 million) to local polysilicon maker Powertec Energy Corporation and a biomedical-focused fund owned by China Development Industrial Bank (CDIB).
Ventureast exits India's Bioserve to Cancer Genetics
US biotech firm Cancer Genetics has acquired India's BioServe Biotechnologies for around $1.9 million, paving an exit for early-stage investor Ventureast.
GIC invests $84m in Philippines hospital business
GIC Private has agreed to invest PHP3.7 billion ($84.5 million) for a 14.4% stake in hospital business of Philippines-based conglomerate Metro Pacific Investments Corp.
India cabinet clears KKR for Gland Pharma deal
The Indian government has given KKR the go-ahead to acquire stakes in Gland Pharma and its affiliate Gland Celcus Bio Chemicals in a deal said to be worth around $230 million.
Fosun expresses interest in Australia’s Healthscope – report
Fosun Group has highlighted the China growth potential of private equity-owned Australian hospital operator Healthscope, prompting speculation it might bid for the asset.
Life sciences player NuSep gets PE funding for Singapore unit
Xeraya Capital, a life sciences investor controlled by Khazanah Nasional, and PE fund JP Asia Prime Capital have invested S$16 million ($12.8 million) in PrIME Biologics, a subsidiary of NuSep that specializes in therapeutic plasma products.
Olympus leads $65m round for India's DM Healthcare - report
Indian hospital chain Aster DM Healthcare is said to be raising $65 million from existing backers Olympus Capital Asia and India Value Fund Advisors (IVFA).
ADB commits $60m to OrbiMed's second Asia fund
The Asian Development Bank (ADB) is to commit up to $60 million to Orbimed Advisors' second Asian healthcare fund - OrbiMed Asia Partners II.
Kunming Pharma, Ping An PE launch healthcare M&A fund
Shanghai-listed Kunming Pharmaceutical Corp. has partnered with a direct investment arm of Ping An Securities to set up a healthcare-focused M&A fund, with a target of RMB500 million ($80 million).